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The article by McCollum et aI. in this issue can be 
viewed from two perspectives: firstly, it presents ex- 
cellent results and outcomes of carotid endarterectomy 
in the U.K. and Ireland - results difficult to overbid, 
especially as they represent the principle of "intention 
to treat", reflecting the clinical reality outside of ran- 
domised trials with their well defined criteria. The 
results with a combined morbidity and mortality at 
30 days of 3.4% and a postoperative (ipsilateral, major 
and minor) stroke rate of 2.1% are very good, especially 
when compared with those results achieved in the 
two studies that form the basis of our present scientific 
paradigm on this topic: NASCET (5.8% combined 
morbidity and mortality) and ECST (7.5%). Secondly, 
the paper can be seen as an example of how a true 
problem can be missed among important, though 
minor, details. Or, to rephrase it: are we missing the 
wood for all the trees? 
What we are presently doing in carotid surgery has 
previously been presented in a number of publications 
such as that by McCollum et al. Now, what should we 
do? We should contribute to the prevention of stroke 
with the help of the reasonably safe and proven sur- 
gical method of carotid endarterectomy. To achieve 
this goal it is not only necessary to present a safe 
method, but also to provide the needed organisational 
details - call it logistics - to exploit he benefits of this 
new method fully. A delay of well over 6.5 months 
between first symptoms and operation isnot consistent 
with an acceptable effort to decrease stroke incidence. 
A doctor's (surgeon's!) delay of 10.8 weeks from review 
in clinic to operation cannot be regarded as optimal 
quality. In combination with a timespan of 16.1 weeks 
between initial referral and review, this may reflect 
the crimping resources in an economically restrained 
health system, but also demonstrates that we have 
failed to make correct priorities. We have still not even 
considered the timelag between initial symptoms and 
first visit to a doctor as an expression of our efforts to 
inform our patients adequately. If we cannot provide 
shorter ways to deal with patients with symptomatic 
carotid stenoses, maybe we should not operate on 
them at all! Hitherto there are no accepted hard sci- 
entific data on the benefit of operating on patients with 
asymptomatic carotid stenoses - and many patients in 
the article can be said to belong to this category. Most 
new strokes occur shortly after a previous TIA or an 
unheralded stroke. With time, the benefits of surgery 
are decreasing, soon reaching the results of non- 
surgical treatment. If as much as 6 months have passed 
by without further symptoms, the carotid stenosis is 
considered tobe asymptomatic, a definition used in the 
ACST (Asymptomatic Carotid Surgery Trial). 1 These 
considerations should place carotid endarterectomy in 
the category of urgent procedures, where the aim must 
be that the patient should be operated upon within 
4-6 (or 4-8) weeks after the initial symptoms - not 27! 
The risk of complications varies with the indication 
for operation, which is also expressed in the guidelines 
for acceptable risk levels for carotid endarterectomy as 
published by the AHA (American Heart Association)2: 
<7% combined stroke morbidity and mortality for 
patients undergoing surgery because of a previous 
stroke, < 5% for patients with TIA and < 3% for patients 
with asymptomatic stenoses. The results presented by 
McCollum et al. resemble very closely those published 
by others for surgery of asymptomatic carotid stenoses. 
Thus, as excellent as the presented results may be, I 
see the article as a sign of warning: do we really know 
what we are doing? Are we performing surgery on 
carotid stenoses or are we using a surgical method to 
prevent stroke? 
Carotid endarterectomy follows the well known 
pattern of a method under development: firstly, the 
pioneering work of breaking new ground, and sec- 
ondly the establishing of the method as feasible by a 
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greater number of users. Thirdly, the phase of over- 
enthusiasm with an excess number of performed pro- 
cedures, sometimes followed by a fourth phase of 
rebound and underutilisation. If the method survives 
this phase, the fifth one is achieved, where the com- 
munity accepts the method per se, but wants it sci- 
entifically tested. Results from these trials with 
succeeding critical discussions may then lead to ap- 
plication of the method. This phase is often initiated 
by committed surgeons in alliance with open minded 
but critical non-surgeons, and may result in consensus 
documents with strictly defined criteria and almost 
rigid recommendations "for the sake of science". Ca- 
rotid endarterectomy is in this phase at present. The 
sixth phase is a synthesis between the scientifically 
acceptable and the clinically reasonable, where the 
intellectual hardware joins up with the software of 
clinical judgement to form the intuitive "art of medi- 
cine". 
We have seen these patterns repeat hemselves over 
and over again (tonsillectomy, coronary bypass, lap- 
aroscopic surgery, etc.), and maybe it is the only, 
although cumbersome, road to achieve knowledge. 
Short cuts mostly result only in time delay - or a bad 
reputation. 
The paper by McCollum et al. can be regarded 
somewhat as a milestone in this development: The 
authors have shown that the surgical procedure of 
carotid endarterectomy can be performed with reason- 
able safety in a heterogeneous clinical environment, 
but have during this process unveiled that it is now 
time to focus the attention on other aspects in order 
to achieve acceptance by the community and fully 
utilise the benefits of the procedure. 
The need for well designed trials is still great, but 
maybe we should start looking in directions other than 
only the strictly methodological, such as: 
(i) are we not fooling ourselves when rigidly de- 
manding a degree of stenosis of > 70%, forgetting that 
this rather arbitrary border value emanates from our 
ignorance of the early days when we designed our 
trials? 
(ii) Are we not ridiculing ourselves when we in 
addition have not even uniformly defined how this 
stenosis hould be measured (in relation to common 
carotid artery, internal carotid artery or suspected bulb 
diameter)? 
(iii) Are we not confounding the facts when relying 
on, many times unproven, correlations between mor- 
phologically measured stenoses from an angiogram 
and a functional stenosis as determined by (differing!) 
ultrasonographic velocities? 
(iv) Are we not single minded when sneering at 
"plaque-morphology" as a subvalid variable in re- 
lation to the "hard fact" of stenosis presentation i
percent, just because our previous trials were not 
designed to answer this many faceted and hard- 
studied aspect? 
(v) Are we not oversimplifying the clinical reality 
when demanding absolute and clear-cut "carotid ter- 
ritory symptoms" before an operation, knowing that 
our understanding of brain circulation and haemo- 
dynamics i  unsatisfactory and in spite of our clinical 
experience that symptoms may well be atypical? 
(vi) Are we not committing a senseless fallacy if 
we accept > 70% stenoses for surgery when they are 
symptomatic, but > 60% when stenoses are asympto- 
matic, as can be deducted from the results of the 
ACAS-study? 
We are facing a fundamental change of concept in the 
handling of patients uffering a stroke, and vascular 
surgeons must take an active part. We must leave 
our operating theatres, join up with angiologists and 
neurologists and speed up the diffusion of knowledge 
amongst our fellow physicians who are not well- 
informed carotid enthusiasts - not to speak of the 
immense task of informing our patients and the society 
of the new tools (not only surgical ones) we now 
have in our hands. Vascular surgeons must be in the 
frontline of the battle against stroke, both to avoid 
unfair exclusion of patients from surgery by the ap- 
plication of over-rigid and pseudo-exact facts, as well 
as uncritically accepting patients for a potentially dan- 
gerous method - a method that at best can correct a 
source of stroke accounting for only about one-third 
of all causes of stroke. 
The present paper will hopefully act as an alarm 
clock by demonstrating the inappropriateness of being 
stuck in mechanical thinking and not addressing what 
now must become one of the most important chal- 
lenges to vascular surgeons: to combine our surgical 
knowledge of the benefits of carotid endarterectomy 
in selected patients with epidemiological f cts in order 
to really have an impact on the stroke incidence. The 
difficulties are no longer to be found in how to operate, 
but rather on whom and when to operate. 
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